PV Bulletin

Online Peptides: Do Not Use, They Can Be Dangerous

The ANSM warns against the dangers of peptides sold online, specifically targeting illegal products such as FastPen 40 mg containing retatrutide.

Primary source: PUBLIÉ LE 19/11/2025 - MIS À JOUR LE 31/08/2026 L’ANSM prend des mesures de police sanitaire à l’encontre des sites inte

Translated From French

PV Bulletin does not take any responsibility for translation errors or omissions, though it has used the best available translation engine.

PV Impact Brief

Urgency: HighConfidence: high

What changed

Implementation of health police measures on 31/08/2026 against the illegal sale of products presented as aGLP-1, specifically targeting FastPen 40 mg as containing retatrutide.

Why it matters

This warning reflects significant safety signals related to unauthorized peptides, which pose serious health risks to consumers, informing risk management and the need for enhanced safety practices.

Action needed

Increased vigilance and reporting obligations on illegal peptide products, with an emphasis on monitoring and managing safety signals pertaining to these substances.

Relevant for
Regulatory Intelligence Lead
Processes impacted
Signal Management
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Aug 31, 2026

Full briefing

Practical implication

Increased vigilance and reporting obligations on illegal peptide products, with an emphasis on monitoring and managing safety signals pertaining to these substances.

The ANSM has issued a warning regarding peptides sold online, particularly those falsely presented as aGLP-1. This includes new health police measures introduced on 31/08/2026, aimed at banning illegal sales of these potentially harmful substances. Retatrutide-containing FastPen 40 mg is specifically highlighted as a concern due to significant health risks associated with its use.

What changed: Implementation of health police measures on 31/08/2026 against the illegal sale of products presented as aGLP-1, specifically targeting FastPen 40 mg as containing retatrutide.

Why it matters: This warning reflects significant safety signals related to unauthorized peptides, which pose serious health risks to consumers, informing risk management and the need for enhanced safety practices.

Practical implication: Increased vigilance and reporting obligations on illegal peptide products, with an emphasis on monitoring and managing safety signals pertaining to these substances.

View original source

  • Source: ANSM (France) - News feed
  • Published at source: 2026-08-31T00:00:00.000Z
  • Discovered by monitor: 2026-08-31T21:32:58.817Z

Published from the regulator source ingestion pipeline after PV impact triage.

#Safety Signal#Safety Signals#Source-ingestion#Regulator-monitor#Translated From French#France#Ansm.sante.fr

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward